Epigenetix
Manufacturing · Florida, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1004 Brooks Ln, Delray Beach, Florida, 3...Phone Number
(561) 543-7569Website
www.epigenetix.comRevenue
<$5 MillionIndustry
About Epigenetix
Epigenetix specializes in developing innovative cancer treatments, focusing on epigenetic changes to enhance precision targeting in lethal cancers. Their flagship product, EP31670 (NEO2734), is a first-in-class oral medication designed for Myelofibrosis and other malignancies, currently undergoing clinical trials at leading cancer centers. The company aims to address various myeloid malignancies, metastatic castrate-resistant prostate cancer, and other aggressive cancers with a unique dual inhibitor approach. With promising early results and a commitment to advancing cancer therapy, Epigenetix is positioned at the forefront of cancer treatment innovation.Explore more
Epigenetix Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Epigenetix
Compare insights from companies similar to Epigenetix, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Epigenetix Tech Stack
A closer look at the technologies used by Epigenetix
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Epigenetix
Sign Up For FreeTo access detailed company insights
Epigenetix specializes in developing innovative cancer treatments, focusing on epigenetic changes to enhance precision targeting in lethal cancers. Their flagship product, EP31670 (NEO2734), is a first-in-class oral medication designed for Myelofibrosis and other malignancies, currently undergoing clinical trials at leading cancer centers. The comp... Read More
